| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |